avapro and ramipril
avapro has been researched along with ramipril in 28 studies
Research
Studies (28)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (53.57) | 29.6817 |
| 2010's | 12 (42.86) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Barton, P; Luker, T; Wenlock, MC | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cattaruzza, M; Hecker, M; Lauth, M | 1 |
| Ader, JL; Bascands, JL; Girolami, JP; Marin-Castaño, ME; Neau, E; Pecher, C; Praddaude, F; Schanstra, JP | 1 |
| Studney, D | 1 |
| Balletta, MM; Bellizzi, V; Conte, G; D'Amora, M; De Nicola, L; Giannattasio, P; Iodice, C; Minutolo, R; Rinaldi, G; Signoriello, G; Tuccillo, S | 1 |
| García-Donaire, JA; Ruilope, LM; Segura, J | 1 |
| Chen, JY; Huang, XS; Lin, SG; Wang, L; Zhou, YL | 1 |
| Azizi, M; Bissery, A; Floch, A; Guyene, TT; Ménard, J; Ozoux, ML; Peyrard, S | 1 |
| Barton, J; Dicker, P; Jensen, C; Mulcahy, D; Nussberger, J; O'Brien, E; Stanton, A | 1 |
| Coleman, CI; Kluger, J; Makanji, S; White, CM | 1 |
| Bakris, GL; de Champlain, J; Locatelli, F; Pieske, B; Ptaszynska, A; Raz, I; Ruilope, L; Weber, MA | 1 |
| Tuttle, KR | 1 |
| Chan, S; Fung, JW; Lau, CP; Lau, ST; Sanderson, JE; Tang, MO; Wang, M; Wang, T; Yeung, L; Yip, GW; Yip, T; Yu, CM | 1 |
| Costanzi, S; Ferraccioli, GF; Ferraro, PM; Fulignati, P; Gambaro, G | 1 |
| Botha, J; Bush, C; Jung, W; Keefe, DL; Palatini, P; Shlyakhto, E | 1 |
| Dicker, P; O'Brien, ET; Stanton, AV | 1 |
| Adamy, C; Berdeaux, A; Crozatier, B; Hittinger, L; Le Corvoisier, P; Michel, JB; Sambin, L; Su, J | 1 |
| Brede, Y; Burnier, M; Lowy, A | 1 |
| Circelli, M; Cremonesi, G; Fogari, R; Mugellini, A | 1 |
| Galantine, V; Gosse, P; Lacraz, A; Rubin, S | 1 |
| Azizi, M; Bobrie, G; Chatellier, G; Frank, M; Ménard, J; Perdrix, L; Plouin, PF | 1 |
| Comi, N; Fuiano, G; Libri, E; Nicotera, R; Pelagi, E; Simeoni, M | 1 |
| Aparicio, C; Bellasi, A; Cannata, A; Cozzolino, M; Ferrari, S; Kohan, DE; Lecchi, V; Mallamaci, F; Mazzaferro, S; Peraro, F; Perna, A; Perticucci, E; Remuzzi, G; Rotondi, S; Ruggenenti, P; Ruggiero, B; Tartaglione, L; Trillini, M; Tripepi, R; Villa, D; Zoccali, C | 1 |
| Li, LJ; Tang, WL; Wang, GM; Wright, JM | 1 |
Reviews
6 review(s) available for avapro and ramipril
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
Topics: Albuminuria; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Irbesartan; Kidney Diseases; Losartan; Prognosis; Ramipril; Tetrazoles | 2002 |
An update of irbesartan and renin-angiotensin system blockade in diabetic nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Diabetic Nephropathies; Diet, Protein-Restricted; Europe; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Practice Guidelines as Topic; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Tetrazoles; United States | 2005 |
Combination delapril/manidipine as antihypertensive therapy in high-risk patients.
Topics: Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Diabetes Complications; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Indans; Irbesartan; Losartan; Nitrobenzenes; Obesity; Olmesartan Medoxomil; Piperazines; Ramipril; Tetrazoles; Valine; Valsartan | 2011 |
Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension.
Topics: Aged; Amides; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Cause of Death; Female; Fumarates; Heart Rate; Humans; Irbesartan; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Myocardial Infarction; Patient Dropouts; Ramipril; Randomized Controlled Trials as Topic; Renin | 2020 |
Trials
12 trial(s) available for avapro and ramipril
| Article | Year |
|---|---|
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; Irbesartan; Male; Middle Aged; Prospective Studies; Proteinuria; Ramipril; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2003 |
[Effects of angiotensin receptor blocker and angiotensin-coverting enzyme inhibitor on vascular endothelial function in type 2 diabetic patients with atherosclerosis: a comparative study].
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Biphenyl Compounds; Brachial Artery; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Irbesartan; Male; Middle Aged; Ramipril; Tetrazoles | 2005 |
Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biotransformation; Biphenyl Compounds; Cross-Over Studies; Cyclic GMP; Dose-Response Relationship, Drug; Heterocyclic Compounds, 3-Ring; Humans; Irbesartan; Male; Natriuresis; Oligopeptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Ramipril; Renin; Renin-Angiotensin System; Single-Blind Method; Tetrazoles | 2006 |
Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
Topics: Adult; Aged; Aged, 80 and over; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Fumarates; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Patient Compliance; Ramipril; Renin; Sodium Chloride Symporter Inhibitors; Tetrazoles | 2007 |
Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial.
Topics: Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Cardiovascular Diseases; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Ramipril; Tetrazoles; Treatment Outcome | 2007 |
The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction.
Topics: Aged; Antihypertensive Agents; Biphenyl Compounds; Diuretics; Drug Therapy, Combination; Echocardiography; Epidemiologic Methods; Exercise Tolerance; Female; Heart Failure, Diastolic; Hong Kong; Humans; Irbesartan; Male; Quality of Life; Ramipril; Tetrazoles; Treatment Outcome; Ventricular Dysfunction, Left | 2008 |
Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Blood Pressure; Docosahexaenoic Acids; Drug Synergism; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Hematuria; Humans; Irbesartan; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Ramipril; Renin-Angiotensin System; Tetrazoles; Triglycerides; Young Adult | 2009 |
Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study.
Topics: Adult; Aged; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brazil; Canada; Double-Blind Method; Drug Administration Schedule; Europe; Female; Fumarates; Humans; Hypertension; Irbesartan; Male; Medication Adherence; Middle Aged; Ramipril; Tetrazoles; Time Factors; Treatment Outcome | 2010 |
Aliskiren monotherapy results in the greatest and the least blood pressure lowering in patients with high- and low-baseline PRA levels, respectively.
Topics: Amides; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Drug Therapy, Combination; Fumarates; Humans; Hypertension; Irbesartan; Ramipril; Renin; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2009 |
Impact of prolonged antihypertensive duration of action on predicted clinical outcomes in imperfectly adherent patients: comparison of aliskiren, irbesartan and ramipril.
Topics: Aged; Amides; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Cardiovascular Diseases; Double-Blind Method; Female; Fumarates; Humans; Hypertension; Irbesartan; Male; Medication Adherence; Ramipril; Risk Factors; Tetrazoles; Treatment Outcome | 2011 |
Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.
Topics: Adolescent; Adult; Aged; Aldosterone; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Bisoprolol; Blood Pressure; Blood Pressure Determination; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Ramipril; Renin; Renin-Angiotensin System; Spironolactone; Tetrazoles; Young Adult | 2014 |
Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Chelating Agents; Cross-Over Studies; Drug Monitoring; Drug Therapy, Combination; Female; Fibroblast Growth Factor-23; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Irbesartan; Male; Middle Aged; Phosphates; Proteinuria; Ramipril; Renal Insufficiency, Chronic; Renin-Angiotensin System; Sevelamer; Treatment Outcome | 2019 |
Other Studies
10 other study(ies) available for avapro and ramipril
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Lipophilicity of acidic compounds: impact of ion pair partitioning on drug design.
Topics: Acids; Albumins; Drug Design; Humans; Hydrogen-Ion Concentration; Lipids; Molecular Structure; Pharmaceutical Preparations; Protein Binding | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
ACE inhibitor and AT1 antagonist blockade of deformation-induced gene expression in the rabbit jugular vein through B2 receptor activation.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Cells, Cultured; Endothelin-1; Gene Expression Regulation; Glyceraldehyde-3-Phosphate Dehydrogenases; In Vitro Techniques; Irbesartan; Male; Peptide Fragments; Perfusion; Pressure; Rabbits; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptor, Endothelin B; Receptors, Angiotensin; Receptors, Bradykinin; Receptors, Endothelin; RNA, Messenger; Swine; Tetrazoles; Transfection; Vasoconstriction | 2001 |
Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Dinoprostone; Drug Administration Schedule; Enzyme Activation; Hypotension; Irbesartan; Kidney; Male; Mice; Mice, Knockout; Nephrons; Organ Specificity; Ramipril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Bradykinin; RNA, Messenger; Tetrazoles; Time | 2002 |
Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Biphenyl Compounds; Cardiac Surgical Procedures; Cohort Studies; Female; Humans; Irbesartan; Lisinopril; Male; Postoperative Complications; Ramipril; Retrospective Studies; Tetrazoles; Valine; Valsartan | 2007 |
Albuminuria reduction: the holy grail for kidney protection.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Biphenyl Compounds; Humans; Irbesartan; Ramipril; Tetrazoles | 2007 |
The cardiac renin-angiotensin system is responsible for high-salt diet-induced left ventricular hypertrophy in mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Biphenyl Compounds; Blotting, Western; Female; Fibrosis; Heart Ventricles; Hypertrophy, Left Ventricular; Immunohistochemistry; Irbesartan; JNK Mitogen-Activated Protein Kinases; Mice; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Ramipril; Renin; Renin-Angiotensin System; Sodium, Dietary; Tetrazoles; Ultrasonography | 2010 |
Malignant hypertension and interferon-beta: a case report.
Topics: Adult; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Bisoprolol; Female; Humans; Hypertension, Malignant; Immunologic Factors; Interferon-beta; Irbesartan; Multiple Sclerosis; Ramipril; Renin-Angiotensin System; Tetrazoles | 2014 |
Successful Use of Aliskiren in a Case of IgA- Mesangial Glomerulonephritis Unresponsive to Conventional Therapies.
Topics: Amides; Biopsy, Needle; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Follow-Up Studies; Fumarates; Glomerulonephritis, IGA; Humans; Immunohistochemistry; Immunosuppressive Agents; Irbesartan; Male; Middle Aged; Prednisone; Ramipril; Retreatment; Time Factors; Treatment Outcome | 2019 |